Homology Medicines, Inc. (FIXX) Financials

FIXX Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 140.1 million 51.9 million
June 30, 2023 169.3 million 50.0 million
March 31, 2023 197.9 million 46.0 million
Dec. 31, 2022 228.5 million 50.5 million

FIXX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -25.3 million 1.7 million
June 30, 2023 -23.7 million 2.4 million
March 31, 2023 -26.3 million 2.4 million
Dec. 31, 2022 -27.2 million 3.1 million

FIXX Net Income

No data available :(

FIXX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 103.3 million - 28.3 million
June 30, 2023 127.1 million - 28.7 million
March 31, 2023 150.0 million - 29.1 million
Dec. 31, 2022 175.0 million - 29.5 million

FIXX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 57.9 million
June 30, 2023 57.8 million
March 31, 2023 57.7 million
Dec. 31, 2022 57.4 million

FIXX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 338000 17.5 million 6.8 million -
June 30, 2023 - 23.0 million 8.2 million -
March 31, 2023 228000 20.0 million 8.3 million -
Dec. 31, 2022 9000 27.1 million 8.1 million -

FIXX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 136000
June 30, 2023 354000 564000
March 31, 2023 802000 587000
Dec. 31, 2022 802000 633000

FIXX

Price: $0.93

52 week price:
0.46
1.76

Earnings Per Share: -2.28 USD

P/E Ratio: -0.31

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 53600

Market Capitalization: 51.9 million

Links: